Form 4: Fulgent Genetics Executive Gao Hanlin Reports Stock Transaction
SEC Form 4 Filing
Chief Scientific Officer of Fulgent Genetics, Gao Hanlin, reports disposition of shares to cover tax obligations.
Summary
- On April 30, 2025, Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, Inc., disposed of 79 shares of common stock to satisfy tax withholding obligations.
- The shares were withheld at a price of $17.35 per share.
- Following the transaction, Gao Hanlin directly owns 963,074 shares of Fulgent Genetics common stock.
- The tax obligations arose from the vesting of restricted stock units granted on April 30, 2021.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, with no significant positive or negative implications.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is a standard procedure for covering tax obligations related to stock-based compensation.
Key Dates
| Date | Description |
|---|---|
| 04/30/2021 | Date of original grant of restricted stock units. |
| 05/03/2021 | Date of original Form 4 filing reporting the grant of restricted stock units. |
| 04/30/2025 | Date of transaction (disposal of shares for tax withholding). |
| 05/02/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Fulgent Genetics, FLGT, Gao Hanlin, Stock Transaction, Beneficial Ownership, Tax Withholding, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.